Should you buy shares of Bellamy's Australia Ltd today?

Bellamy's Australia Ltd (ASX:BAL) shares hit a low of just $8.63 last week – almost 48% below their peak price.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors have an opportunity to buy Bellamy's Australia Ltd (ASX: BAL) at a considerable discount to the price levels from late in 2015.

Indeed, Bellamy's, a producer of organic infant food and formula, was one of the market's top-performing shares last year, soaring as much as 900% to a high of $16.50. This was largely due to the soaring sales and earnings reported by the company, together with its improving margins as demand for its products soared in Australia and Asia.

However, investors have become increasingly uncertain about the future of the business, which has seen its share price ravaged. The shares fell more than 14% between Monday and Tuesday last week, hitting a low of just $8.63, although they did regain nearly 23% to close at $10.59 on Friday. That's still a 35.8% discount compared to their high from December.

Notably, shares of Blackmores Limited (ASX: BKL) and a2 Milk Company Ltd (Australia) (ASX: A2M) have also come under intense pressure. The pair have fallen 3% and 0.3% today, respectively, while they're both trading between 25% and 30% below their 52-week highs.

The most recent uncertainty facing the three businesses relates to tougher regulations that will be imposed by China for companies selling infant formula in an effort to bolster food safety. All three companies produce infant formula, with enormous growth potential in the world's second-biggest economy.

Bellamy's will need to obtain a registration certificate by the China Food and Drug Administration (CFDA) by 1 January, 2018, meaning it can continue to operate as it has been until that date. Although there are plenty of uncertainties associated with the changes at this point, the company is confident it can meet the requirements and continue to thrive in the country well into the future.

Bellamy's said: "Bellamy's has been successfully operating in China for over six years. Bellamy's has a strong 'bricks and mortar' business in China selling the company's (Guobiao) compliant formula. In addition, our products sold in China via 'bricks and mortar' businesses already have labelling in Chinese."

It added: "With Bellamy's infant formula and manufacturing facilities already registered in China, we believe we are well placed to transition to the new requirements once they are known."

Although there are a number of uncertainties facing the business in the near-term, the potential long-term opportunity is still enormous. Indeed, tougher regulations will also make it tougher for competitors to enter the Chinese market, potentially enhancing Bellamy's market share within the region.

Foolish takeaway

As a reminder, any investment should always be considered in the context of a balanced and diversified portfolio. Although an investment in Bellamy's today is by no means without risk, and its shares are still not cheap, per se, investors should certainly be watching Bellamy's shares closely – especially if they do fall any further – as they could still be capable of generating sound returns for long-term investors.

Motley Fool contributor Ryan Newman owns shares of Bellamy's Australia. The Motley Fool Australia owns shares of Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »